FCS Press Releases

FCS physicians present at the Society for Immunotherapy of Cancer Annual Meeting in San Diego.

FCS is now offering an advanced maintenance therapy program that slows the progression of relapsed/refractory multiple myeloma (RRMM). The treatment, teclistamab (TECVAYLI®), is a type of rapidly evolving cancer therapy that uses the body’s immune system to fight cancer.

Pharmacy experts and leaders from Florida Cancer Specialists & Research Institute, LLC (FCS) are contributing to improving cancer care globally as they join fellow oncology professionals for the NCODA 2023 International Fall Summit in Orlando this week.

Research conducted by Florida Cancer Specialists & Research Institute, LLC (FCS) is featured this week among the latest advancements and findings in cancer care at the European Society of Medical Oncology (ESMO) Congress in Madrid, Spain.

FCS clinicians and senior leaders are among the industry experts who will present breakthrough data, research and clinical strategies at the Florida Society of Clinical Oncology (FLASCO) Fall Session in Orlando this month.

Executive leaders of Florida Cancer Specialists & Research Institute (FCS) will serve on the faculty for the Association for Value-Based Cancer Care 2023 Summit & Educational Program in New York, NY on Oct. 18 – 20.

A best practice clinical program developed by FCS is ensuring that patients with certain blood disorders achieve maximum clinical benefits from the use of oral medications.

Richard McDonough, MD has been appointed as FCS Director of Patient Advocacy

Bradley Monk, MD will join Florida Cancer Specialists & Research Institute as Medical Director of Late-Phase Research effective in January 2024.

Hematologists and medical oncologists Bahaa Amer, MD and Savan Shah, MD join FCS in Sarasota and Clearwater

PQI in Action for medically integrated teams on blood cancers and disorders co-authored by FCS clinicians

Tarek Eldawy, MD, medical oncologist and hematologist, joins Florida Cancer Specialists & Research Institute in Central Florida

Director of Drug Development Manish Patel, MD is the co-author for two manuscripts published in the New England Journal of Medicine.

Raphael Bosse, MD, PhD, hematologist and medical oncologist joins Florida Cancer Specialists & Research Institute’s Naples-Goodlette location

Central Florida Cancer Care Center/Radiation Oncology Consultants becomes FCS Orlando Radiation Oncology and FCS Sanford Radiation Oncology

Hematologist and medical oncologist Tien Do, MD joins Florida Cancer Specialists & Research Institute Tallahassee Cancer Center